NanoVibronix Total Assets from 2010 to 2025

NAOV Stock

USD 4.18 0.00 0.00%

NanoVibronix Total Assets yearly trend continues to be fairly stable with very little volatility. Total Assets are likely to outpace its year average in 2025. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2012-12-31

Previous Quarter

5.7 M

Current Value

4.7 M

Quarterly Volatility

2.7 M

Yuan Drop

Covid

Check NanoVibronix financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NanoVibronix's main balance sheet or income statement drivers, such as Depreciation And Amortization of 945, Interest Expense of 268.8 K or Selling General Administrative of 2.4 M, as well as many indicators such as Price To Sales Ratio of 10.59, Dividend Yield of 0.0 or PTB Ratio of 5.25. NanoVibronix financial statements analysis is a perfect complement when working with NanoVibronix Valuation or Volatility modules.

Check out the analysis of NanoVibronix Correlation against competitors.

For more information on how to buy NanoVibronix Stock please use our How to Invest in NanoVibronix guide.

Latest NanoVibronix's Total Assets Growth Pattern

Below is the plot of the Total Assets of NanoVibronix over the last few years. Total assets refers to the total amount of NanoVibronix assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in NanoVibronix books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. NanoVibronix's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in NanoVibronix's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 6.67 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

NanoVibronix Total Assets Regression Statistics

	Arithmetic Mean	3,751,810
	Geometric Mean	2,282,269
	Coefficient Of Variation	86.44
	Mean Deviation	2,967,536
	Median	2,036,000
	Standard Deviation	3,243,024
	Sample Variance	10.5T
	Range	8.3M
	R-Value	0.85
	Mean Square Error	3.1T
	R-Squared	0.73
	Significance	0.000029
	Slope	580,015
	Total Sum of Squares	157.8T

NanoVibronix Total Assets History

	2025	8.1 M
	2024	7.7 M
	2023	6.7 M
	2022	5.9 M
	2021	8.6 M
	2020	8.2 M
	2019	2 M

Other Fundumenentals of NanoVibronix

Intangibles To Total Assets

NanoVibronix Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Common Stock	Current Deferred Revenue	Short Term Debt	Property Plant Equipment	Net Tangible Assets	Capital Surpluse	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.89	-0.85	-0.87	0.47	0.73	0.08	1.0	-0.23	-0.12	-0.62	0.65	0.87	0.84	0.58	0.72	-0.47	0.34	0.54	0.35
Total Stockholder Equity	0.89		-0.88	-0.83	0.46	0.7	-0.38	0.9	-0.51	-0.04	-0.75	0.6	0.91	0.84	0.66	0.77	-0.41	0.25	0.32	0.24
Net Debt	-0.85	-0.88		0.7	-0.49	-0.43	0.14	-0.86	0.46	-0.25	0.78	-0.27	-0.88	-0.81	-0.74	-0.75	0.15	-0.21	-0.44	-0.57
Retained Earnings	-0.87	-0.83	0.7		-0.54	-0.8	0.05	-0.87	0.22	0.13	0.7	-0.76	-0.88	-0.92	-0.69	-0.82	0.42	-0.17	-0.24	-0.09
Accounts Payable	0.47	0.46	-0.49	-0.54		0.43	-0.05	0.46	0.04	0.52	-0.63	0.09	0.66	0.69	0.72	0.81	-0.18	-0.35	-0.23	0.07
Net Receivables	0.73	0.7	-0.43	-0.8	0.43		-0.13	0.73	-0.17	-0.34	-0.46	0.85	0.64	0.64	0.38	0.54	-0.75	0.24	0.23	-0.13
Total Liab	0.08	-0.38	0.14	0.05	-0.05	-0.13		0.06	0.65	-0.11	0.36	-0.06	-0.21	-0.1	-0.22	-0.2	0.08	0.15	0.41	0.27
Total Current Assets	1.0	0.9	-0.86	-0.87	0.46	0.73	0.06		-0.25	-0.13	-0.63	0.65	0.87	0.84	0.58	0.72	-0.48	0.34	0.54	0.35
Common Stock	-0.23	-0.51	0.46	0.22	0.04	-0.17	0.65	-0.25		-0.14	0.56	-0.14	-0.32	-0.29	-0.36	-0.3	0.1	0.06	0.03	-0.02
Current Deferred Revenue	-0.12	-0.04	-0.25	0.13	0.52	-0.34	-0.11	-0.13	-0.14		-0.51	-0.63	0.2	0.15	0.55	0.29	0.27	-0.56	-0.39	0.2
Short Term Debt	-0.62	-0.75	0.78	0.7	-0.63	-0.46	0.36	-0.63	0.56	-0.51		-0.27	-0.86	-0.79	-0.95	-0.81	0.24	0.12	0.02	-0.15
Property Plant Equipment	0.65	0.6	-0.27	-0.76	0.09	0.85	-0.06	0.65	-0.14	-0.63	-0.27		0.5	0.5	0.21	0.37	-0.67	0.41	0.32	-0.31
Net Tangible Assets	0.87	0.91	-0.88	-0.88	0.66	0.64	-0.21	0.87	-0.32	0.2	-0.86	0.5		0.91	0.85	0.88	-0.34	0.14	0.23	0.27
Capital Surpluse	0.84	0.84	-0.81	-0.92	0.69	0.64	-0.1	0.84	-0.29	0.15	-0.79	0.5	0.91		0.84	0.96	-0.23	0.02	0.16	0.26
Deferred Long Term Liab	0.58	0.66	-0.74	-0.69	0.72	0.38	-0.22	0.58	-0.36	0.55	-0.95	0.21	0.85	0.84		0.86	-0.07	-0.09	0.0	0.18
Long Term Investments	0.72	0.77	-0.75	-0.82	0.81	0.54	-0.2	0.72	-0.3	0.29	-0.81	0.37	0.88	0.96	0.86		-0.16	-0.1	0.01	0.2
Short Long Term Debt	-0.47	-0.41	0.15	0.42	-0.18	-0.75	0.08	-0.48	0.1	0.27	0.24	-0.67	-0.34	-0.23	-0.07	-0.16		-0.1	-0.12	0.29
Net Invested Capital	0.34	0.25	-0.21	-0.17	-0.35	0.24	0.15	0.34	0.06	-0.56	0.12	0.41	0.14	0.02	-0.09	-0.1	-0.1		0.87	0.23
Net Working Capital	0.54	0.32	-0.44	-0.24	-0.23	0.23	0.41	0.54	0.03	-0.39	0.02	0.32	0.23	0.16	0.0	0.01	-0.12	0.87		0.51
Capital Stock	0.35	0.24	-0.57	-0.09	0.07	-0.13	0.27	0.35	-0.02	0.2	-0.15	-0.31	0.27	0.26	0.18	0.2	0.29	0.23	0.51

Click cells to compare fundamentals

About NanoVibronix Financial Statements

NanoVibronix investors use historical fundamental indicators, such as NanoVibronix's Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in NanoVibronix. Please read more on our technical analysis and fundamental analysis pages.

		Last Reported	Projected for Next Year
	Total Assets	7.7 M	8.1 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for NanoVibronix Stock Analysis

When running NanoVibronix's price analysis, check to measure NanoVibronix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NanoVibronix is operating at the current time. Most of NanoVibronix's value examination focuses on studying past and present price action to predict the probability of NanoVibronix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NanoVibronix's price. Additionally, you may evaluate how the addition of NanoVibronix to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC